"The purpose of this statement is to provide the current available scientific knowledge on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age." - Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age
Additional Resource:
Web link
Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age
Implementation Tool
Link
Link
PDF
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.